Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
ID 3 & 4
| Generic | Brand | Pharmacologic Category | Common Indications | Classifications | Essential Knowledge |
|---|---|---|---|---|---|
| clindamycin (PO, IV) | Cleocin | Lincosamide antibiotic | SSTI, pharyngitis Activity against: MRSA | Key Side Effects: diarrhea, Clostridioides difficile diarrhea US Boxed Warning: Clostridioides difficile-associated diarrhea (CDAD) has been reported w/ use of nearly all antibacterial agents, including clindamycin, and may range in severity from mild di | |
| sulfamethoxazole and trimethoprim (PO, IV) | Bactrim, Bactrim DS | Sulfonamide antibiotic | SSTI, Cystitis, Pyelonephritis, Opportunistic infection prophylaxis Activity against: MRSA, Enterobacteriaceae | Key Side Effects: nausea, vomiting, diarrhea, skin rashes (rarely SJS or TEN), photosensitivity, crystalluria, hyperkalemia, increased serum creatinine, hypersensitivity reactions | |
| nitrofurantoin (PO) | Macrobid | Urinary antibiotic | Cystitis Activity against: Escherichia coli | Key Side Effects: nausea, pulmonary fibrosis (chronic use) | |
| fosfomycin (PO) | Monurol | Urinary antibiotic | Cystitis Activity against: Escherichia coli | Key Side Effects: headache, nausea, diarrhea | |
| vancomycin (IV, PO) | Vancocin | Glycopeptide antibiotic | IV: SSTI, HAP, meningitis, endocarditis, CRBSI PO: CDI Activity against: MRSA, Clostridioides difficile (PO only) | Key Side Effects: nephrotoxicity, vancomycin infusion reaction, ototoxicity | |
| metronidazole | Flagyl | Antibiotic | Anaerobic infections, CDI Activity against: Bacteroides species, Clostridioides difficile | Key side Effects: nausea, metallic taste, disulfiram reaction w/ alcohol, peripheral neuropathy (long term use) | |
| mupirocin (topical) | Bactroban | Antibiotic | MRSA decolonization | Key Side Effects: no major side effects | |
| terbinafine (PO, topical) | Lamisil | Allylamine antifungal | Onychomycosis | Topical: OTC | Key Side Effects: nausea, abdominal pain, diarrhea, elevated hepatic transaminases, headache |
| acyclovir (PO, IV) | Zovirax | Antiviral | Herpes simplex virus | Key Side Effects: nausea, increased hepatic transaminases, crystalluria | |
| valacyclovir (PO) | Valtrex | Antiviral | Herpes simplex virus | Key Side Effects: nausea, increased hepatic transaminases | |
| fluconazole (PO, IV) | Diflucan | Azole antifungal | Vulvovaginal candidiasis, oropharyngeal candidiasis, invasive candidiasis | Key Side Effects: nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases | |
| ketoconazole (PO, topical) | Nizoral | Azole antifungal | Tinea infections | Topical: OTC | Key Side Effects: nausea, abdominal pain, diarrhea, QTc prolongation, increased hepatic transaminases US Boxed Warnings: serious hepatotoxicity, including cases with a fatal outcome or requiring liver transplantation have occurred; may cause QTc prolo. |
| oseltamivir (PO) | Tamiflu | Neuraminidase inhibitor antiviral | Influenza | Key Side Effects: nausea, vomiting, neuropsychiatric events in pediatric patients (rare) | |
| nystatin (PO) | —— | Polyene antifungal | Oropharyngeal candidiasis | Key Side Effects: phlebitis, diarrhea, vomiting, anemia, fever | |
| nystatin (topical) | Nystop | Polyene antifungal | Cutaneous and mucocutaneous fungal infections | Key Side Effects: burning, itching | |
| micafungin (IV) | Mycamine | Echinocandin antifungal | Invasive candidiasis | Key Side Effects: no major side effects | |
| betamethasone and clotrimazole (topical) | Lotrisone | Glucocorticoid and Azole antifungal | Cutaneous fungal infections | Key Side Effects: burning, itching, dryness, skin atrophy | |
| tobramycin (IV, inhaled) | Tobi (inhaled) | Aminoglycoside antibiotic | HAP, Cystic fibrosis (nebulized only) Activity against: Escherichia coli, Pseudomonas aeruginosa | Key Side Effects: nephrotoxicity, ototoxicity | |
| neomycin + polymyxin B + bacitracin (topical, ophthalmic) | Topical: Neosporin Ophthalmic: Neo-Polycin | Topical antibiotic | Topical infection prevention Ocular infections | Neosporin: OTC | Key Side Effects: reddening, itching |
| nirmatrelvir + ritonavir (PO) | Paxlovid | Antiviral | COVID-19 | Key Side Effects: diarrhea, dysgeusia US Boxed Warnings: significant drug interactions; strong CYP3A inhibitor | |
| remdesivir (IV) | Veklury | Antiviral | COVID-19 | Key Side Effects: hyperglycemia, renal impairment | |
| emtricitabine + tenofovir disoproxil fumarate (PO) | Truvada | Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) | HIV infection, PreP, PEP | Key Side Effects: decreased bone mineral density, kidney injury, nausea, diarrhea US Boxed Warnings: post treatment acute exacerbation of hepatitis B, risk of drug resistance w/ use for preexposure prophylaxis | |
| emtricitabine (NRTI) + tenofovir alafenamide (NRTI) + bictegravir (INSTI) (PO) | Biktarvy | Nuceloside/ Nucleotide Reverse Transcriptase Inhibitor (NRTI) and Integrase strand transfer inhibitor (INSTI) | HIV infection | Key Side Effects: increased serum bilirubin, headache, weight gain, insomnia, diarrhea, nausea US Boxed Warnings: post treatment acute exacerbation of hepatitis B |
Created by:
Kateloki
Popular Pharmacology sets